Moderate Chronic Plaque Psoriasis
2 clinical trials · Condition
◉ Watch Moderate Chronic Plaque Psoriasis
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis (NCT04123795) | UCB Biopharma SRL | 2020-01-21 |
Track Moderate Chronic Plaque Psoriasis automatically
Every clearance here is in the API, with alerts when new ones post.